Hainan Honz Pharmaceutical Co - Asset Resilience Ratio

Latest as of June 2021: 0.27%

Hainan Honz Pharmaceutical Co (300086) has an Asset Resilience Ratio of 0.27% as of June 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥7.01 Million

≈ $1.03 Million USD Cash + Short-term Investments

Total Assets

CN¥2.58 Billion

≈ $377.59 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2019)

This chart shows how Hainan Honz Pharmaceutical Co's Asset Resilience Ratio has changed over time. Check 300086 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Hainan Honz Pharmaceutical Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300086 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥7.01 Million	0.27%
Total Liquid Assets	CN¥7.01 Million	0.27%

Asset Resilience Insights

Limited Liquidity: Hainan Honz Pharmaceutical Co maintains only 0.27% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Hainan Honz Pharmaceutical Co Industry Peers by Asset Resilience Ratio

Compare Hainan Honz Pharmaceutical Co's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Hainan Honz Pharmaceutical Co (2014–2019)

The table below shows the annual Asset Resilience Ratio data for Hainan Honz Pharmaceutical Co.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2019-12-31	0.94%	CN¥20.53 Million ≈ $3.00 Million	CN¥2.19 Billion ≈ $321.11 Million	+0.30pp
2017-12-31	0.63%	CN¥14.15 Million ≈ $2.07 Million	CN¥2.24 Billion ≈ $327.19 Million	-0.71pp
2016-12-31	1.34%	CN¥29.36 Million ≈ $4.30 Million	CN¥2.19 Billion ≈ $320.39 Million	-44.24pp
2015-12-31	45.58%	CN¥952.50 Million ≈ $139.38 Million	CN¥2.09 Billion ≈ $305.81 Million	+42.98pp
2014-12-31	2.59%	CN¥50.00 Million ≈ $7.32 Million	CN¥1.93 Billion ≈ $282.00 Million	--

pp = percentage points

About Hainan Honz Pharmaceutical Co

SHE:300086 China Drug Manufacturers - Specialty & Generic

Market Cap

$430.90 Million

CN¥2.94 Billion CNY

Market Cap Rank

#12873 Global

#3751 in China

Share Price

CN¥6.47

Change (1 day)

+3.03%

52-Week Range

CN¥5.63 - CN¥13.71

All Time High

CN¥17.75